BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, June 16, 2025
Home
»
Topics
»
Disease categories and therapies
» Endocrine/metabolic
Endocrine/metabolic
RSS
FDA designates orphan drug for Peyronie's disease
April 19, 1996
Troglitazone NDA filing expected soon
April 19, 1996
RF-1051 cleared to enter phase II
April 19, 1996
Obesity gene identified
April 19, 1996
Warner-Lambert reports NPY1 antagonist
April 19, 1996
Warner-Lambert, Pfizer intend to copromote atorvastatin
April 19, 1996
FDA approves new indication for Pravachol
April 19, 1996
ACAT inhibitor reported by Nisshin Flour Milling
April 19, 1996
Human Genome Sciences' research into cathepsin K
April 19, 1996
Fujisawa describes cathepsin L/B inhibitor of fungal origin
April 19, 1996
Previous
1
2
…
1804
1805
1806
1807
1808
1809
1810
1811
1812
Next
RSS